rs1554111768
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5
The NM_001372066.1(TFAP2A):c.656G>T(p.Arg219Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/20 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R219S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001372066.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TFAP2A | NM_001372066.1 | c.656G>T | p.Arg219Leu | missense_variant | 4/7 | ENST00000379613.10 | NP_001358995.1 | |
TFAP2A-AS2 | NR_145448.1 | n.121C>A | non_coding_transcript_exon_variant | 1/1 | ||||
TFAP2A | NM_001042425.3 | c.638G>T | p.Arg213Leu | missense_variant | 4/7 | NP_001035890.1 | ||
TFAP2A | NM_001032280.3 | c.632G>T | p.Arg211Leu | missense_variant | 4/7 | NP_001027451.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TFAP2A | ENST00000379613.10 | c.656G>T | p.Arg219Leu | missense_variant | 4/7 | 1 | NM_001372066.1 | ENSP00000368933 | A1 | |
TFAP2A-AS2 | ENST00000645232.1 | n.121C>A | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
TFAP2A-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | May 19, 2023 | The TFAP2A c.650G>T variant is predicted to result in the amino acid substitution p.Arg217Leu. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant has been confirmed as de novo in an individual tested at PreventionGenetics with phenotypes overlapping TFAP2A-related disease (Internal Data, PreventionGenetics). This variant is interpreted as likely pathogenic. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 22, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at